Philadelphia, PA, United States of America

Phillipe Loher

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Phillipe Loher

Introduction

Phillipe Loher is an accomplished inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical diagnostics and therapeutics. His work focuses on the use of human miRNAs in diagnosing and treating various human conditions and diseases.

Latest Patents

Loher holds a patent titled "Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases." This patent discloses novel compositions, methods, and systems for determining whether a subject has, is at risk of developing, or is at a given stage of a condition afflicting a tissue of interest. The methods can also determine the tissue or cell provenance of a biological sample based on the expression level of one or more of the novel miRNA and isomiR sequences. The compositions and methods can be utilized to diagnose diseases or disorders, prognose their stages, and even develop treatments.

Career Highlights

Loher is affiliated with Thomas Jefferson University, where he continues to advance his research and innovations. His work has the potential to significantly impact the medical field by providing new diagnostic and therapeutic options for patients.

Collaborations

Loher collaborates with notable colleagues, including Isidore Rigoutsos and Eric Londin, who contribute to his research endeavors.

Conclusion

Phillipe Loher's innovative work in the field of miRNAs showcases his dedication to improving medical diagnostics and therapies. His contributions are paving the way for advancements in understanding and treating human diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…